Nature Medicine
4, 395 - 396 (1998)
doi:10.1038/nm0498-395
Death to a blood vessel, death to a tumorDavid A. ChereshDepartments of Immunology and Vascular Biology The Scripps Research Institute La Jolla, California 92037, USA email: cheresh@scripps.edu Suppression of endothelial cell  V 3 activity by TNF and IFN- disrupts angiogenesis and promotes the demise of malignant melanoma (pages 408−414).
REFERENCES
- Brooks, P.C., Clark, R.A.F. & Cheresh, D.A. Requirement of vascular integrin aV$3 for angiogenesis. Science 264, 569−571 (1994). | PubMed | ISI | ChemPort |
- Ruegg, C. et al. Evidence for the involvement of endothelial cell integrin
 V 3 in the disruption of the tumor vasculature induced by TNF and IFN- . Nature Med. 4, 408−414 (1998). | Article | PubMed | ISI | ChemPort |
- Brooks, P.C. et al. Integrin V3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79, 1157−1164 (1994). | Article | PubMed | ISI | ChemPort |
- Friedlander, M. et al. Definition of two angiogenic pathways by distinct V33 integrins. Science 270, 1500−1502 (1995). | PubMed | ISI | ChemPort |
- Stromblad, S., Becker, J.C., Yebra, M., Brooks, P.C. & Cheresh, D.A. Suppression of p53 and p21 expression by vascular cell integrin V3 during angiogenesis in vivo. J. Clin. Invest. 98, 426−433 (1996). | PubMed | ISI | ChemPort |
- Gutheil, J.C. et al. Phase I study of Vitaxin, an anti-angiogenic humanized monoclonal antibody to vascular integrin V3, Proc. Am. Soc. Clin. Oncol. (in the press).
- Yuan, F. et al. Time dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor antibody. Proc. Natl. Acad. Sci, USA 93, 14765−14770 (1996). | Article | PubMed | ChemPort |
- Elicieri, B.P., Klemke, R., Stromblad, S. & Cheresh, D.A. Integrin V3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis. J. Cell Biol. (in the press).
- Campbell, J.J. et al. Biology of cherrtokine and classical chemoattractant receptors: Differential requirements for adhesion triggering versus chemotactic responses in lymphoid cells. J. Cell Biol. 134, 255−266 (1996). | Article | PubMed | ISI | ChemPort |
- Vassboth, F.S. et al. Negative feedback regulation of human platelets via autocrine activation of the platelet-derived growth factor alpha receptor. J. Biol. Chem. 269, 13874−13879 (1994). | PubMed |
|
